Health and Life Sciences news
Homemade nut-based dairy analogs raise questions about bacterial risks
Trio of journal articles highlights consumer knowledge gaps in safe preparation methods
Purdue researchers create biocompatible nanoparticles to enhance systemic delivery of cancer immunotherapy
Purdue University researchers are developing and validating patent-pending poly (lactic-co-glycolic acid), or PLGA, nanoparticles modified with adenosine triphosphate, or ATP, to enhance immunotherapy effects against malignant tumors.
$6.7M in federal grants awarded to develop tech to monitor, treat chronic eye diseases
Research teams led by a faculty member in Purdue University’s College of Engineering will use two grants from the National Eye Institute totaling $6.7 million to further develop specialized smart soft contact lenses that continuously monitor or treat chronic ocular diseases like glaucoma, corneal neovascularization and dry eye syndromes.
Purdue researchers explore noninvasive method for sampling drug response
Harnessing a pervasive type of cellular messenger shows early experimental promise as a routine way of sampling and monitoring the body’s response to prescription drug exposure.
Exposure to cigarette smoke increases cancer risk in dogs
Dogs are humans’ best friends. Need to quickly locate a bomb? There’s a dog for that. Can’t see very well? There’s a dog for that. Searching for a lost hiker in the mountains or survivors in an earthquake, diagnosing illness, comforting the bereft — there are dogs for every need.
Discovery points to new approach to treating liver cancer
A breakthrough in the understanding of the relationship between a naturally occurring enzyme and the liver cancer drug sorafenib could improve the effectiveness of the drug, which currently prolongs the life of liver cancer patients for only two to three months. A study of the relationship between the enzyme DDX5, liver cancer and sorafenib, published in the Nature journal Cell Death Disease, points to the potential for a more effective therapy that combines existing anti-cancer drugs with treatments that spur production of this enzyme.
Purdue engineer works to improve formulation of RNA-based pharmaceuticals
A team of university and industry researchers is developing new formulations and manufacturing processes for the messenger RNA (mRNA) delivery systems used in some COVID vaccines.
